|PROJECT TITLE||USING MONITORME FOR A CLINICAL VALIDATION STUDY IN A SMALL COPD PATIENT COHORT|
|Funding body||Med Tech Trials Innovation Support Grant (MTT-ISG), Medilink East Midlands, East Midlands Academic Health Science Network|
The overarching aim is to validate the MonitorMe device in clinical practice.
MonitorMe is a telephone and Class IIA medical device supplied for the non-critical monitoring of vital signs in the domestic environment. These include peripheral capillary oxygen saturation (SpO2), pulse rate, pulse transit time, temperature and blood pressure (via a commercially available CE marked cuff). An automated call captures the data together with responses to a health questionnaire and directs the data to the patient’s electronic record. Remote trend analysis by care professionals will identify any patients in need of an intervention.
The objective of MonitorMe is to improve the efficiency of care professionals by helping them to identify those patients with the greatest need of a health intervention, and at the same time to dramatically improve patient’s health outcomes.
|Objectives||The objectives of this study are to confirm:
|Methods||Mixed methods clinical validation study|
|Outcomes||The key outcome is to validate MonitorMe in terms of data accuracy, feasibility and patient acceptability.|
|Outputs||Peer reviewed publications and conference presentations.|
|Impact||If MonitorMe is shown to be effective patients will benefit from being able to go home earlier and convalesce in familiar surroundings following discharge; this might lead to quicker recovery times for patients and the empowerment of both patients and their loved ones of knowing their vital signs are being monitored whilst they recover at home.|